Laboratory Corporation of America Holdings, commonly known as Labcorp (NYSE: LH), is a global life sciences company that provides comprehensive clinical laboratory and drug development services. The company operates a broad network of laboratories, patient service centers and specialty testing sites to deliver diagnostic information and testing solutions that support patient care, clinical decision-making and population health initiatives.
Labcorp’s core businesses encompass clinical laboratory testing and pharmaceutical development services. Its diagnostics offerings include routine and specialty clinical tests, anatomic pathology, molecular and genomic testing, toxicology and companion diagnostics. On the drug development side, the company provides preclinical and clinical research services, central laboratory support, biomarker development, regulatory and commercialization services to pharmaceutical and biotechnology clients.
The company serves a wide range of customers including physicians, hospitals and health systems, biopharmaceutical companies, employers and public health agencies. Labcorp’s operations extend across the United States and into international markets through laboratory facilities, partnerships and service centers, enabling it to support clinical trials and diagnostic needs on a global scale.
Organized to combine diagnostic testing with drug development capabilities, Labcorp has developed integrated service offerings designed to streamline clinical development and accelerate the translation of laboratory findings into clinical and commercial outcomes. As a publicly traded company, it is positioned to leverage laboratory infrastructure, data analytics and scientific expertise to meet evolving needs in healthcare and life sciences.
AI Generated. May Contain Errors.
Free LH Stock Alerts